Cargando…
H(2) antagonists, proton pump inhibitors and COVID-19
Autor principal: | Hirota, Kazuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784200/ https://www.ncbi.nlm.nih.gov/pubmed/35067766 http://dx.doi.org/10.1007/s00540-021-03032-5 |
Ejemplares similares
-
Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
por: Kishore, E, et al.
Publicado: (2023) -
Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021) -
Effects of Proton Pump Inhibitors and H(2) Receptor Antagonists on the Ileum Motility
por: Kurt, Atilla, et al.
Publicado: (2011) -
Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023) -
Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)